breast cancer: be more common than cancers

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents breast
Weight: 0.78
, prostate cancer
Weight: 0.76
, heart disease
Weight: 0.75
, tumor
Weight: 0.72
, illness
Weight: 0.72
Siblings lung cancer
Weight: 0.80
, lymphoma
Weight: 0.60
, skin cancer
Weight: 0.40
, liver cancer
Weight: 0.39

Related properties

Property Similarity
be more common than cancers 1.00
be more common than other cancers 0.99
be more common in countries 0.78
be more common in breast 0.77
be more common in females 0.77
is more common 0.77
be more common than than general population 0.76
be more common in developed countries 0.76
be more common in left breast 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.96
Similarity weight: 0.78
Evidence: 0.53
Plausible(heart disease, be more common in countries)
Evidence: 0.08
¬ Typical(breast cancer, be more common than cancers)
0.48
Rule weight: 0.66
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.32
Plausible(heart disease, be more common in developed countries)
Evidence: 0.08
¬ Typical(breast cancer, be more common than cancers)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.32
¬ Plausible(heart disease, be more common in developed countries)
0.04
Rule weight: 0.09
Evidence weight: 0.62
Similarity weight: 0.78
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.53
¬ Plausible(heart disease, be more common in countries)

Remarkability exclusitivity betweem a parent and a child

0.34
Rule weight: 0.58
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.23
¬ Remarkable(heart disease, be more common in developed countries)
0.24
Rule weight: 0.58
Evidence weight: 0.53
Similarity weight: 0.78
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.50
¬ Remarkable(heart disease, be more common in countries)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.62
Similarity weight: 0.76
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.40
¬ Remarkable(lymphoma, be more common in developed countries)
0.06
Rule weight: 0.13
Evidence weight: 0.54
Similarity weight: 0.78
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.49
¬ Remarkable(lymphoma, be more common in countries)

Remarkability from parent implausibility

0.32
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.78
Evidence: 0.53
Plausible(heart disease, be more common in countries)
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.29
¬ Plausible(breast cancer, be more common than cancers)
0.32
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.32
Plausible(heart disease, be more common in developed countries)
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.29
¬ Plausible(breast cancer, be more common than cancers)

Remarkability from sibling implausibility

0.33
Rule weight: 0.60
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.49
Remarkable(lymphoma, be more common in countries)
Evidence: 0.78
¬ Plausible(lymphoma, be more common in countries)
0.31
Rule weight: 0.60
Evidence weight: 0.68
Similarity weight: 0.76
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.40
Remarkable(lymphoma, be more common in developed countries)
Evidence: 0.75
¬ Plausible(lymphoma, be more common in developed countries)

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.61
Similarity weight: 1.00
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.55
¬ Salient(breast cancer, be more common than cancers)

Similarity expansion

0.81
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.99
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.80
¬ Remarkable(breast cancer, be more common than other cancers)
0.64
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.78
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.76
¬ Remarkable(breast cancer, be more common in countries)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
0.63
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.77
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.63
¬ Remarkable(breast cancer, be more common in females)
0.63
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.96
¬ Remarkable(breast cancer, be more common in breast)
0.62
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.88
¬ Remarkable(breast cancer, is more common)
0.62
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.83
¬ Remarkable(breast cancer, be more common than than general population)
0.62
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.94
Remarkable(breast cancer, be more common than cancers)
Evidence: 0.83
¬ Remarkable(breast cancer, be more common in left breast)
0.61
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.77
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.09
¬ Typical(breast cancer, be more common in breast)
0.55
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.99
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.78
¬ Salient(breast cancer, be more common than other cancers)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.22
¬ Typical(breast cancer, be more common than than general population)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.77
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.31
¬ Plausible(breast cancer, be more common in breast)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.50
¬ Salient(breast cancer, be more common in developed countries)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.50
¬ Salient(breast cancer, be more common than than general population)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.34
¬ Plausible(breast cancer, be more common than than general population)
0.48
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.77
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.60
¬ Salient(breast cancer, be more common in breast)
0.48
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.99
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.61
¬ Plausible(breast cancer, be more common than other cancers)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.62
¬ Salient(breast cancer, be more common in countries)
0.44
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.77
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.71
¬ Salient(breast cancer, is more common)
0.44
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.77
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.36
¬ Typical(breast cancer, is more common)
0.44
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.76
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.70
¬ Salient(breast cancer, be more common in left breast)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.78
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.48
¬ Plausible(breast cancer, be more common in countries)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.76
¬ Salient(breast cancer, be more common in females)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.48
¬ Plausible(breast cancer, is more common)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.76
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.41
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.76
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.51
¬ Plausible(breast cancer, be more common in left breast)
0.41
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.99
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.57
¬ Typical(breast cancer, be more common than other cancers)
0.39
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.78
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.45
¬ Typical(breast cancer, be more common in countries)
0.39
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.76
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.43
¬ Typical(breast cancer, be more common in left breast)
0.34
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.77
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.67
¬ Plausible(breast cancer, be more common in females)
0.31
Rule weight: 0.85
Evidence weight: 0.47
Similarity weight: 0.76
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.22
Rule weight: 0.85
Evidence weight: 0.34
Similarity weight: 0.77
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.72
¬ Typical(breast cancer, be more common in females)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.55
Salient(breast cancer, be more common than cancers)
Evidence: 0.08
¬ Typical(breast cancer, be more common than cancers)
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.29
Plausible(breast cancer, be more common than cancers)
Evidence: 0.08
¬ Typical(breast cancer, be more common than cancers)

Typicality and Rermarkability incompatibility between a parent and a child

0.19
Rule weight: 0.51
Evidence weight: 0.49
Similarity weight: 0.76
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.54
¬ Typical(heart disease, be more common in developed countries)
0.17
Rule weight: 0.51
Evidence weight: 0.42
Similarity weight: 0.78
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.62
¬ Typical(heart disease, be more common in countries)

Typicality and Rermarkability incompatibility between siblings

0.02
Rule weight: 0.14
Evidence weight: 0.19
Similarity weight: 0.78
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.86
¬ Typical(lymphoma, be more common in countries)
0.02
Rule weight: 0.14
Evidence weight: 0.18
Similarity weight: 0.76
Evidence: 0.94
¬ Remarkable(breast cancer, be more common than cancers)
Evidence: 0.87
¬ Typical(lymphoma, be more common in developed countries)

Typicality inheritance from parent to child

0.19
Rule weight: 0.48
Evidence weight: 0.51
Similarity weight: 0.76
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.54
¬ Typical(heart disease, be more common in developed countries)
0.16
Rule weight: 0.48
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.08
Typical(breast cancer, be more common than cancers)
Evidence: 0.62
¬ Typical(heart disease, be more common in countries)